Director/PDMR Shareholding

GlaxoSmithKline PLC 17 October 2007 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 16 October 2007 of an increase in their notional interests in Ordinary shares at a price of £12.55 per share and Ordinary Share ADRs at a price of $51.61 per ADR following the notional re-investment of the dividend paid to shareholders on 11 October 2007. Ordinary shares ADRs Dr JP Garnier 6,595.27 Mr J S Heslop 2,169.35 Mr W C Louv 348.02 Dr M M Slaoui 387.43 666.92 Mrs C E Bruck Slaoui 33.74 15.18 Mr R M Bondy 2,308.46 Mr J M Clarke 1,785.46 Mr M Dunoyer 869.42 Dr R G Greig 751.12 Mr D Learmouth 318.17 Mr D J Phelan 1,156.73 Dr D Pulman 751.12 Mr D M Stout 2,755.18 Mr C Viehbacher 1,195.39 Mr A P Witty 2,385.59 The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period. This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a) and 3.1.4R(1)(b). S M Bicknell Company Secretary 17 October 2007 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings